EDTA Chelation

EDTA combined with Procaine, vitamins (C, B-complex), magnesium, and trace minerals intended for heavy-metal chelation under medical supervision.

• Chelates certain metals (lead, cadmium; limited evidence for others)
• Supports antioxidant pathways

• EDTA: binds divalent and trivalent metals for renal excretion.
• Vitamin C +: Provides antioxidant support during chelation.
• Procaine: Known for its chelating properties, aids in the removal of heavy metals from tissues and organs, supporting overall detoxification.

• Low calcium levels (EDTA)
• Kidney strain
• Nausea, hypotension
• Nephrotoxicity: Edetate CALCIUM disodium is potentially nephrotoxic. Renal tubular acidosis and fatal nephrosis may occur.

These intravenous infusions should not be administered to patients with:

• Chronic renal insufficiency
• Congestive heart failure
• Atrial fibrillation, and known allergies on vitamins, minerals, and related substances. and other ingredients contained in the IV infusion bag.
• This should not be administered to patients below 18 years old.
• EDTA is contradicted for those who have active renal disease or anuria; hepatitis.
• Pregnancy & breastfeeding.
• Kidney disease
• Hypocalcemia

• Increased renal clearance of some metals and minerals
• Drug Interactions: Digoxin, diuretics, potassium-depleting medicines. If the patient is taking any medicine, check first for any possible drug interaction before use. Do not take alcohol, sleep aids, or tranquilizers of other CNS depressants.
• EDTA x Chloramphenicol (Systemic): Myelosuppressive Agents may enhance the myelosuppressive effect of Chloramphenicol (Systemic).
• EDTA x Cladribine: May enhance the myelosuppressive effect of Myelosuppressive Agents.
• EDTA x Dipyrone: May enhance the adverse/toxic effect of Myelosuppressive Agents. Specifically, the risk for agranulocytosis and pancytopenia may be increased.
• EDTA x BCG (Intravesical): Myelosuppressive Agents may diminish the therapeutic effect of BCG (Intravesical).

These are general categories of references typically supporting nutrient-based IV therapy mechanisms:

1. Modern Nutrition in Health and Disease, 12th Ed.
2. NIH Office of Dietary Supplements – Fact Sheets (Vitamin C, B12, Magnesium, Zinc, etc.)
3. European Food Safety Authority (EFSA) scientific opinions on micronutrients
4. PubMed-indexed reviews on IV vitamin therapy, antioxidant therapy, NAC, glutathione, and EDTA chelation
5. Drug–nutrient interaction data from Lexicomp & Micromedex